Latest Period
Q2 2026
CUSIP: 05330T205
Latest Period
Q2 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.36
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 0 institutions filings for Q2 2026.
Security key
05330T205
Latest holder period
Q2 2026
13F holders
0
13D/G owners
2
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 05330T205:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BioStar Ventures III, L.P. | 4.3% | $250,559 | 175,216 | BioStar Ventures III, L.P. | 30 Jun 2025 | |||
| CVI Investments, Inc. | 4.9% | $293,700 | 116,087 | CVI Investments, Inc. | 31 Dec 2024 |
As of 30 Jun 2026, 0 institutional investors reported holding 0 shares of Autonomix Medical, Inc. - Common Stock, $0.001 par value per share (AMIX). This represents 0% of the company’s total 4,074,791 outstanding shares.
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 0 | $0 | -$144,765 | $0.36 | 0 |
| 2026 Q1 | 357,711 | $144,759 | +$71,229 | $0.39 | 15 |
| 2025 Q4 | 170,519 | $91,036 | -$11,088 | $0.55 | 17 |
| 2025 Q3 | 112,988 | $122,026 | +$18,539 | $1.08 | 17 |
| 2025 Q2 | 77,923 | $122,720 | +$36,334 | $1.57 | 18 |
| 2025 Q1 | 53,471 | $93,577 | -$104,120 | $1.75 | 12 |
| 2024 Q4 | 112,970 | $424,768 | +$424,768 | $3.76 | 13 |